SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 691.64 |
| Enterprise Value ($M) | 665.11 |
| Book Value ($M) | 106.89 |
| Book Value / Share | 0.56 |
| Price / Book | 6.47 |
| NCAV ($M) | 99.23 |
| NCAV / Share | 0.52 |
| Price / NCAV | 6.97 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.67 |
| Return on Assets (ROA) | -0.48 |
| Return on Equity (ROE) | -0.64 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.02 |
| Current Ratio | 7.02 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 132.78 |
| Assets | 140.44 |
| Liabilities | 33.55 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Two Seas Capital LP | 4.40 | -7.24 | |
| 13G | Morgan Stanley | 10.30 | 1,248.33 | |
| 13D/A | Whitefort Capital Management, LP | 6.80 | ||
| 13G/A | BlackRock Inc. | 6.20 | 19.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 210,882 | 949,145 | 22.22 | |
| 189,057 | 545,454 | 34.66 | |
| 166,648 | 611,720 | 27.24 | |
| 161,171 | 699,615 | 23.04 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABCL – AbCellera Biologics Inc. | ABOS – Acumen Pharmaceuticals, Inc. |
| ACAD – ACADIA Pharmaceuticals Inc. | ACLX – Arcellx, Inc. |